1110 Stock Chart & Stats
€0.06
€0.00(0.00%)
At close: 4:00 PM EST
€0.06
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.06 - €0.07
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€9.96M
Enterprise Value€7.14M
Total Cash (Recent Filing)€1.89M
Total Debt (Recent Filing)€3.26M
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding6,357,630
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)3.66
Price to Sales (P/S)10.52
P/FCF Ratio-1.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.01Price Target Upside11590.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Proprietary Silicon Nitride TechnologySintx’s focus on silicon nitride (Si3N4) is a durable technical moat: the material’s performance characteristics for implants create product differentiation versus conventional biomaterials. This supports multi-year commercialization opportunities in healthcare and potential adjacent industrial applications.
Recent Equity Financings Bolster LiquidityThe recent ~$4.5M private placement plus an earlier $500k ATM materially extends near-term runway, enabling working capital, commercialization and business development initiatives. This funding reduces immediate insolvency risk and buys time to execute longer-term commercialization plans.
Active Capital-structure ManagementManagement is proactively reworking warrants and equity positions to address share overhang and reduce future cash exercise demands. These moves can stabilize reported equity and align financing mechanics with strategic objectives, improving capital flexibility if operational progress follows.
Bears Say
Structural Unprofitability And Cash BurnPersistent negative operating and free cash flow indicate the business is consuming capital faster than it generates revenue. This structural cash burn requires repeated financings and undermines sustainable growth unless the company achieves durable revenue scale or material margin improvement.
Eroded Equity And Listing Compliance RiskA sharp decline in equity has driven debt-to-equity higher and triggered a Nasdaq noncompliance notice. Listing pressure can force hurried, dilutive financings or distress transactions, limiting strategic optionality and raising long-term execution risk for commercialization plans.
High Dilution Risk From Warrant-heavy FinancingsRecent financings feature extensive warrant coverage and anti-dilution mechanics, creating substantial potential share overhang. Over time, warrant exercises or cashless conversions can markedly dilute existing shareholders and impair the company’s ability to build a stable equity base for long-term investors.
1110 FAQ
What was Sintx Technologies Inc’s price range in the past 12 months?
Sintx Technologies Inc lowest stock price was €0.06 and its highest was €0.07 in the past 12 months.
What is Sintx Technologies Inc’s market cap?
Sintx Technologies Inc’s market cap is €9.96M.
When is Sintx Technologies Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sintx Technologies Inc’s earnings last quarter?
Currently, no data Available
Is Sintx Technologies Inc overvalued?
According to Wall Street analysts Sintx Technologies Inc’s price is currently Undervalued.
Does Sintx Technologies Inc pay dividends?
Sintx Technologies Inc does not currently pay dividends.
What is Sintx Technologies Inc’s EPS estimate?
Sintx Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sintx Technologies Inc have?
Sintx Technologies Inc has 6,357,630 shares outstanding.
What happened to Sintx Technologies Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sintx Technologies Inc?
Currently, no hedge funds are holding shares in DE:1110
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sintx Technologies Inc
Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.
1110 Stock 12 Month Forecast
Average Price Target
€7.01
▲(11590.13% Upside)
Technical Analysis
Strata Skin Sciences
―
Solana Company
―
Vyome Holdings
―
Co-Diagnostics
―
Tenon Medical, Inc.
―
Options Prices
Currently, No data available
---







